DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

Modi S, Saura C, Yamashita T. et al
DESTINY-Breast01 Investigators. Trastuzumab deruxtecan in previously treated HER2-positive breast cancer.

N Engl J Med 2020;
382 (07) 610-621

Download Bibliographical Data

Access:
Access: